敦煌種業(600354.SH)終止重大資產重組事項 16日復牌
格隆匯12月13日丨敦煌種業(600354.SH)公佈,自公司股票停牌以來,公司及相關各方積極推進本次重大資產重組的相關工作,並就本次重大資產重組事項反覆溝通、磋商和談判。由於交易各方未能就本次重組預案相關交易協議的核心條款達成一致意見,經認真聽取各方意見,為切實保護公司和投資者利益,經公司及相關各方審慎研究及友好協商,決定終止籌劃本次重大資產重組事項。
公司股票將於2019年12月16日(星期一)開市起復牌,並於12月16日上午10:30-11:30通過上海證券交易所“上證e互動”網絡平台召開關於公司終止重大資產重組事項的投資者説明會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.